Webinar: MultiTAA-Specific T Cells: A Novel Treatment for Cancer
Webinar Summary
In this webinar, Juan F. Vera, President & CEO, Marker Therapeutics, presents a multi-antigen targeting technique for T cell therapies, providing a potent and durable anti-tumor response, without the need for genetic modification.
This presentation was recorded as part of the Virtual Immune Cell Therapy Symposium on September 27, 2023.
Up Next